SCHEMBL6402479

SCHEMBL6402479

CC(C)(C)[Si]1(C(C)(C)C)OC[C@H]2O[C@@H](n3cnc4c(N)nc(N)nc43)[C@H](O)[C@@H]2O1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ STING1 Q86WV6 8/20 0.49
▸ HSP90B1 P14625 1/20 0.47
▸ LMNA P02545 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ RAPGEF3 O95398 2/20 0.44
▸ GMNN O75496 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ RAPGEF4 Q8WZA2 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ HINT1 P49773 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ RXFP1 Q9HBX9 2/20 0.44
▸ NT5E P21589 1/20 0.43
▸ PDE3B Q13370 1/20 0.42
▸ PDE3A Q14432 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6398930 0.87 STING1 (0.59) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL1582124 0.87 HINT1 (0.39) STING1HSP90B1HINT1ADORA3NT5E
SCHEMBL6395562 0.83 STING1 (0.63) STING1PDE3BPDE3A
SCHEMBL5963100 0.82 STING1 (0.47) STING1HSP90B1LMNAKMT2ARAPGEF3
SCHEMBL12806732 0.80 PDE4A (0.46) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL12936600 0.80 STING1 (0.61) STING1
SCHEMBL12936674 0.80 STING1 (0.61) STING1
SCHEMBL16707282 0.75 RXFP1 (0.42) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL12803683 0.75 RXFP1 (0.42) STING1LMNAKMT2ARAPGEF3GMNN
SCHEMBL12936667 0.75 RXFP1 (0.42) STING1LMNAKMT2ARAPGEF3GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501830-A1 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES Actelion Pharmaceuticals Ltd. (CH) 2005-02-02 — — EP disclosed
WO-2003093267-A1 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES ACTELION PHARMACEUTICALS LTD (CH) 2003-11-13 — — WO disclosed
Send feedback